BioNTech 3 juin 2026 Opportunities in the Oncology Market: Positioning for the Next Billion-Dollar Catalyst with BioNTech, Vidac Pharma, and Pfizer - news.financial
BioNTech 30 mai 2026 BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA - statnews.com
BioNTech 27 mai 2026 BioNTech Stock Is Stuck in the Red. A Cancer Drug Could Change the Narrative. - Barron's
BioNTech 22 mai 2026 BioNTech Unveils Promising Clinical Data for Pumitamig and Gotistobart at ASCO 2026 - Quiver Quantitative
BioNTech 22 mai 2026 ASCO26: After ivonescimab stumble, rivals unveil their own bispecific data - FirstWord Pharma
BioNTech 15 mai 2026 BioNTech’s Clinical and Corporate Overhaul: Cancer Data Improves as COVID Era Ends - AD HOC NEWS
BioNTech 5 mai 2026 BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback - Fierce Pharma
BioNTech 5 mai 2026 BioNTech to cut fifth of workforce as it winds down Covid vaccine production - Financial Times
BioNTech 5 mai 2026 BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs - BioSpace
BioNTech 4 mai 2026 BioNTech Faces a Defining Moment as Clinical Wins Clash with Earnings Reality - AD HOC NEWS